Rhodiola rosea
Rhodiola rosea is an adaptogenic root standardised to rosavins and salidroside, used for fatigue resistance, stress and endurance. Its best-supported use is reducing mental and physical fatigue under stress; it is not a testosterone booster and any direct ergogenic performance effect is small and inconsistent.
01 Overview
Rosavins and salidroside are thought to modulate the stress response, monoamine neurotransmitters and cellular energy pathways, underlying rhodiola's reputation as an anti-fatigue adaptogen. Trials in stressed or fatigued people fairly consistently show reduced fatigue and improved subjective wellbeing, while direct effects on exercise performance are mixed and generally small.
Users take standardised extract for fatigue, focus, stress tolerance and perceived endurance, typically dosed before activity. It is well tolerated and non-hormonal. The main side effects are mild overstimulation, insomnia or irritability, and it can theoretically interact with antidepressants and stimulants.
02 Mechanism
Adaptogenic root (rosavins, salidroside) that modulates the HPA stress axis, monoamine neurotransmission and cellular energy metabolism to improve resistance to fatigue.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Standardised extract | 200–400 mg/day | Oral | Standardised to ~3% rosavins / 1% salidroside; taken before activity. |
| Higher single-dose use | 400–600 mg/day | Oral | Upper range for acute anti-fatigue use. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Reduced fatigueThe most consistent benefit: reduced mental and physical fatigue in stressed individuals. | modest | Clinical | |
| Improved stress tolerance / moodReported improvements in stress symptoms and wellbeing. | modest / subjective | Observational | |
| Small/inconsistent exercise-performance effectDirect effects on endurance and strength performance are minor and not reliably reproduced. | small / mixed | Clinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Overstimulation / insomniaJitteriness, irritability or difficulty sleeping, particularly with later-day dosing. | Mild | Common | Observational | |
| Interaction with antidepressants / stimulantsTheoretical additive effects with SSRIs, MAOIs or stimulants. | Moderate | Interaction | Anecdotal |